pre-update Archives

网络研讨会点播

ON DEMAND [ISoP Webinar] – Physiologically Based Pharmacokinetic (PBPK) Applications in Model Informed Drug Development (MIDD) – Do You Know the Current Landscape of Regulatory Acceptance?

Model Informed Drug Development (MIDD) is a critical component in the drug development process and…

Danielle Pillsbury2024 年 9 月 16 日

Guide

Non-CRF 数据管理最佳实践指南

Danielle Pillsbury2024 年 9 月 16 日

Poster

动态靶介药物处置（Target-Mediated Drug Disposition, TMDD）

Abstract Methods: We have developed a novel pharmacokinetic model, termed dynamic TMDD, to mechanistically describe the…

Renee Fisher2024 年 9 月 16 日

Poster

ATG-101，一种针对 PD-L1/4-1BB 的双特异性抗体，用于实体瘤治疗的半机制模型

Abstract Trimer formation is key to the pharmacology of the bispecific ATG-101 but is difficult…

Renee Fisher2024 年 9 月 16 日

Poster

布林妥莫单抗（Blinatumomab）三聚体形成

Insights from a Mechanistic PKPD Model on the Implications for Switching from Infusion to Subcutaneous…

Renee Fisher2024 年 9 月 16 日

On-Demand Webinar

基于定量系统药理学（QSP）的肿瘤学首次人体试验研究

Renee Fisher2024 年 9 月 16 日

Article

行业洞察：药物重新定位，解锁新的治疗可能性

Panelists: Adekemi Taylor, PhD, VP, Quantitive Science Services at CertaraJoab Williamson, Director of Clinical Operations,…

Danielle Pillsbury2024 年 9 月 16 日

Publication

A tutorial on physiologically based pharmacokinetic approaches in lactation research

The tutorial by Amita Pansari, Xian Pan, Lisa M. Almond, and Karen Rowland-Yeo examines the…

Danielle Pillsbury2024 年 9 月 16 日

Blog

All You Need to Know About Non-CRF Data in Clinical Trials

We look at the role of non-CRF data in clinical trials, and best practices for…

Simona Colucci2024 年 9 月 16 日

Blog

The SDTM Mapping Process Simplified

SDTM mapping can be one of the most challenging programming problems in a clinical trial…

Simona Colucci2024 年 9 月 16 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

pre-update

ON DEMAND [ISoP Webinar] – Physiologically Based Pharmacokinetic (PBPK) Applications in Model Informed Drug Development (MIDD) – Do You Know the Current Landscape of Regulatory Acceptance?

Non-CRF 数据管理最佳实践指南

动态靶介药物处置（Target-Mediated Drug Disposition, TMDD）

ATG-101，一种针对 PD-L1/4-1BB 的双特异性抗体，用于实体瘤治疗的半机制模型

布林妥莫单抗（Blinatumomab）三聚体形成

基于定量系统药理学（QSP）的肿瘤学首次人体试验研究

行业洞察：药物重新定位，解锁新的治疗可能性

A tutorial on physiologically based pharmacokinetic approaches in lactation research

All You Need to Know About Non-CRF Data in Clinical Trials

The SDTM Mapping Process Simplified

订阅时事通讯

快捷链接

解决方案

联系我们